Patents Assigned to CMPD LICENSING, LLC
-
Patent number: 10064949Abstract: The present embodiments may relate to topically delivered compounded medications for the treatment of scar tissue, skin disorders, and/or other ailments. In one aspect, a transdermal cream or gel may provide for the effective administration of multiple medications simultaneously. Preferably, a silicone-based gel may be provided as a base composition and may have a non-zero percentage of silicone or silicone variant. The silicone-based gel may comprise cyclopentasiloxane, polysilicone-11, dimethicone, and C30-45 alkyl cetearyl dimethicone crosspolymer, and include several active ingredients, such as glucocorticoids, antihistamines, and nerve depressants. The silicone-based gel may include a combination of fluticasone, loratadine, and gabapentin. The concentrations of fluticasone and loratadine may be relatively low, while that of gabapentin moderately high. The silicone-based gel may also have one or more local anesthetics, such as prilocaine and/or lidocaine.Type: GrantFiled: March 13, 2017Date of Patent: September 4, 2018Assignee: CMPD Licensing, LLCInventors: Jay Richard Ray, II, Charles D. Hodge
-
Patent number: 9999604Abstract: A compounded topical solution may include approximately 85% to approximately 95% (v/v) diclofenac sodium topical solution, 1.5% (w/w), and approximately 5% to approximately 15% (v/v) lidocaine hydrochloride topical solution, 4% USP.Type: GrantFiled: November 17, 2016Date of Patent: June 19, 2018Assignee: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20180147211Abstract: A method of treating or preventing a bacterial infection of a subject may include combining linezolid and a diluent to form a treatment solution and topically administering the treatment solution to the subject to bath a skin area with the treatment solution. The treatment solution may be made using linezolid oral tablets.Type: ApplicationFiled: January 26, 2018Publication date: May 31, 2018Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20180147212Abstract: A method of treating or preventing a bacterial infection of a subject may include combining levofloxacin and a diluent to form a treatment solution and topically administering the treatment solution to the subject to bath a skin area with the treatment solution. The treatment solution may include levofloxacin oral solution.Type: ApplicationFiled: January 26, 2018Publication date: May 31, 2018Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20180133178Abstract: A compounded topical solution may include approximately 85% to approximately 95% (v/v) diclofenac sodium topical solution, 1.5% (w/w), and approximately 5% to approximately 15% (v/v) lidocaine hydrochloride topical solution, 4% USP.Type: ApplicationFiled: November 17, 2016Publication date: May 17, 2018Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Patent number: 9962391Abstract: A method of compounding a transdermal cream may include grinding one or more tablets of a Non-Steroidal Anti-Inflammatory Drug (NSAID) and one or more nerve depressants, anticonvulsants, or combinations thereof to produce a fine powder. The find powder may be wetted and added to an eutectic mixture of lidocaine and prilocaine in an emulsified topical cream in the form of a lidocaine 2.5%-prilocaine 2.5% cream. The compounded transdermal may include between 0.05% and 0.15% by weight meloxicam, between 1.0% and 5.0% by weight gabapentin, and at least 80% by weight of the lidocaine 2.5%-prilocaine 2.5% cream.Type: GrantFiled: November 17, 2016Date of Patent: May 8, 2018Assignee: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Patent number: 9925141Abstract: In one aspect, a dry formulation for the effective administration of multiple medications simultaneously for one or more ailments may be provided. The dry formulations include one or more of the following actives in combination with pharmaceutically acceptable excipients or additives: a) at least one antibiotic; b) at least one anti-inflammatory steroid; and c) at least one antifungal agent.Type: GrantFiled: October 17, 2016Date of Patent: March 27, 2018Assignee: CMPD LICENSING LLCInventor: Jay Richard Ray, II
-
Publication number: 20180078492Abstract: A topical composition for treating fungal skin infections with associated inflammation may include making or administering to the affected skin area an antifungal and steroid, such as a corticosteroid. Certain compositions may include antifungals such as itraconazole or econazole and corticosteroids such as fluticasone, fluocinonide, or clobetasol. The antifungal and steroid may be within a cream. In one example, a commercially available econazole nitrate cream may be used in conjunction with a commercially available fluocinonide cream or commercially available clobetasol cream to treat the affected skin area.Type: ApplicationFiled: September 22, 2016Publication date: March 22, 2018Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20180036227Abstract: A topical composition that may be a lotion, gel, ointment, foam, cream, or emulsion, and that may include urea and fluocinonide. The topical composition may include between approximately 10% to approximately 25% urea by weight. The topical composition may further include between approximately 0.050% to approximately 0.075% fluocinonide by weight.Type: ApplicationFiled: August 3, 2017Publication date: February 8, 2018Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20170333466Abstract: A dry formulation may include one or more active agents including one or more anti-infective agents such as an anti-bacterial agent, anti-fungal agent, or other anti-active agent. The dry formulation may be prepared for administration by mixing the dry formulation with a diluent. In one example, the diluent is a hydrocortisone and acetic acid solution or a sodium chloride solution. The combined preparation may be administered to the ear or skin to treat or prevent an infection.Type: ApplicationFiled: May 23, 2017Publication date: November 23, 2017Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20170333467Abstract: A method of treating or preventing one or both of a bacterial infection or fungal infection of a foot of a subject includes combining a diluent and at least one of a clindamycin solution or an erythromycin solution to form a footbath solution. The method may further include topically administering the footbath solution to the subject. Administering may include contacting with the footbath solution a skin area of the foot of the subject that is infected or suspected to be infected.Type: ApplicationFiled: June 16, 2017Publication date: November 23, 2017Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20170333464Abstract: The present application relates to compounded compositions, methods of making compounded compositions, and methods of using compounded compositions. For example, disclosed herein are compounded compositions and methods of making compounded compositions comprising one or more anti-infective agents such as mupirocin.Type: ApplicationFiled: August 3, 2017Publication date: November 23, 2017Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20170326167Abstract: The present application relates to compounded compositions, methods of making compounded compositions, kits comprising compounded compositions, containers comprising compounded compositions, and methods of using compounded compositions. The present application also relates to anti-infective agents and methods of using anti-infective agents. For example, disclosed herein are compounded compositions comprising an anti-bacterial agent, an anti-fungal agent, and an excipient base and methods of using a compounded composition to treat or prevent a bacterial infection, a fungal infection, or both, or a suspected bacterial infection, a suspected fungal infection, or both. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.Type: ApplicationFiled: July 31, 2017Publication date: November 16, 2017Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20170312276Abstract: The present application relates to compounded compositions, methods of making compounded compositions, kits comprising compounded compositions, containers comprising compounded compositions, and methods of using compounded compositions. The present application also relates to anti-infective agents and methods of using anti-infective agents. For example, disclosed herein are compounded compositions comprising an anti-bacterial agent, an anti-fungal agent, and an excipient base and methods of using a compounded composition to treat or prevent a bacterial infection, a fungal infection, or both, or a suspected bacterial infection, a suspected fungal infection, or both. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.Type: ApplicationFiled: July 17, 2017Publication date: November 2, 2017Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20170273897Abstract: A compounded topical composition may include an antiviral component, a topical base component, and a local anesthetic component. The antiviral component may include fine powder obtained by grinding oral tablets of one or more antiviral actives. The topical component may include the local anesthetic component. The local anesthetic component may be present in an amount between about 2% and about 8% by weight of the compounded topical composition and the antiviral component may be present in an amount between 4% and 12% by weight of the compounded topical composition. The antiviral component may include acyclovir, valaciclovir, penciclovir, famciclovir, or combinations thereof, and the topical base component may be a lidocaine topical, a lidocaine and prilocaine topical, or both.Type: ApplicationFiled: March 23, 2017Publication date: September 28, 2017Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20170273898Abstract: A compounded topical composition may be compounded by combining a local anesthetic component with a topical base composition. The local anesthetic component may comprise lidocaine hydrochloride monohydrate and the topical base composition may comprise an Acyclovir 5% Ointment containing 5% acyclovir by weight and polyethylene glycol.Type: ApplicationFiled: April 11, 2017Publication date: September 28, 2017Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20170246140Abstract: The present application relates to compounded compositions, methods of making compounded compositions, and methods of using compounded compositions. For example, disclosed herein are compounded compositions and methods of making compounded compositions comprising one or more anti-infective agents such as mupirocin.Type: ApplicationFiled: May 17, 2017Publication date: August 31, 2017Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Publication number: 20170239277Abstract: The present application relates to compounded compositions, methods of making compounded compositions, and methods of using compounded compositions. For example, disclosed herein are compounded compositions and methods of making compounded compositions comprising one or more anti-infective agents such as mupirocin and doxcycline.Type: ApplicationFiled: February 23, 2017Publication date: August 24, 2017Applicant: CMPD LICENSING, LLCInventor: Jay Richard Ray, II
-
Patent number: 9724315Abstract: The present embodiments relate to topically delivered medication (compounded) for treatment of pain, inflammation, muscle fatigue, spasms, and/or other ailments. A transdermal cream may provide the effective topical administration of multiple medications simultaneously. The transdermal cream may include a salt load of approximately 30% or greater. The transdermal cream may include a unique base composition such that the transdermal cream may be able to remain stable and avoid degradation for six months or more and capable of effective delivery of active ingredient concentrations exceeding approximately 40% or more of the total formulation weight. The active ingredients may include a nerve depressant, NSAID, muscle relaxant, opiate agonist, local anesthetic, NMDA receptor antagonist, and a tricyclic antidepressant. In one embodiment, the transdermal cream may comprise ketamine HCL, gabapentin, clonidine HCL and baclofen.Type: GrantFiled: December 16, 2011Date of Patent: August 8, 2017Assignee: CMPD Licensing, LLCInventors: Jay Richard Ray, II, Charles D. Hodge
-
Patent number: 9724294Abstract: The present embodiments relate to topically delivered compounded medications. A transdermal cream may provide the effective topical administration of multiple medications simultaneously. The transdermal cream may include low concentrations of local anesthetics, a NSAID, an anticonvulsant, and/or other active ingredients. For instance, the transdermal cream may include lidocaine, prilocaine, meloxicam, and lamotrigine and/or topiramate. Alternatively, the transdermal cream may include a lidocaine/prilocaine base cream to which is added a fine powder of one or more ground up medications to form a compounded medication. The compounded medication in powder form may be generated from grinding up tablets of NSAIDs, anticonvulsants, nerve depressants, antidepressants, muscle relaxants, NMDA receptor antagonists, opiate or opioid agonists, and/or other agents. The compounded medication in powder form may include meloxicam, lamotrigine, topiramate, and/or other active ingredients.Type: GrantFiled: August 1, 2012Date of Patent: August 8, 2017Assignee: CMPD Licensing, LLCInventors: Jay Richard Ray, II, Charles D. Hodge